ANIP [NASD]
ANI Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-4.52 Insider Own5.40% Shs Outstand16.14M Perf Week2.19%
Market Cap498.59M Forward P/E9.91 EPS next Y3.01 Insider Trans4.49% Shs Float12.79M Perf Month-3.53%
Income-63.40M PEG- EPS next Q0.24 Inst Own73.40% Short Float5.00% Perf Quarter-18.19%
Sales226.10M P/S2.21 EPS this Y-80.30% Inst Trans2.93% Short Ratio4.30 Perf Half Y-33.75%
Book/sh19.91 P/B1.50 EPS next Y118.12% ROA-10.30% Target Price40.67 Perf Year-11.49%
Cash/sh4.60 P/C6.48 EPS next 5Y2.20% ROE-24.40% 52W Range22.73 - 60.23 Perf YTD-35.29%
Dividend- P/FCF- EPS past 5Y-64.40% ROI-4.20% 52W High-50.49% Beta1.03
Dividend %- Quick Ratio2.70 Sales past 5Y10.90% Gross Margin49.20% 52W Low31.19% ATR1.85
Employees601 Current Ratio3.80 Sales Q/Q18.30% Oper. Margin-27.40% RSI (14)52.25 Volatility6.30% 6.99%
OptionableYes Debt/Eq0.89 EPS Q/Q- Profit Margin-28.00% Rel Volume0.94 Prev Close28.71
ShortableYes LT Debt/Eq0.89 EarningsMay 10 BMO Payout- Avg Volume148.66K Price29.82
Recom2.30 SMA204.71% SMA502.32% SMA200-17.69% Volume139,979 Change3.87%
Nov-02-21Initiated Truist Buy $70
May-07-20Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-12-19Initiated Guggenheim Buy
May-10-19Downgrade Raymond James Strong Buy → Outperform $73 → $82
Oct-16-17Reiterated Canaccord Genuity Buy $60 → $66
Jul-31-17Initiated Canaccord Genuity Buy $60
Feb-22-17Downgrade ROTH Capital Buy → Neutral
Jun-23-16Initiated Raymond James Strong Buy $68
May-24-16Downgrade Standpoint Research Buy → Hold
Nov-13-15Initiated Standpoint Research Buy $54
Sep-28-15Upgrade ROTH Capital Neutral → Buy $67 → $60
Aug-05-15Reiterated Oppenheimer Outperform $74 → $65
Aug-04-15Reiterated ROTH Capital Neutral $70 → $67
Jul-31-15Reiterated Oppenheimer Outperform $72 → $74
Jul-15-15Reiterated ROTH Capital Neutral $60 → $70
Jun-23-15Reiterated Oppenheimer Outperform $61 → $67
May-18-15Reiterated ROTH Capital Neutral $78 → $60
May-06-15Reiterated Oppenheimer Outperform $69 → $61
Apr-10-15Downgrade ROTH Capital Buy → Neutral $78
Feb-26-15Reiterated ROTH Capital Buy $65 → $78
May-20-22 06:50AM  
May-10-22 08:05AM  
06:50AM  
May-09-22 09:15AM  
May-05-22 08:55AM  
Apr-19-22 06:50AM  
Apr-11-22 06:50AM  
Mar-24-22 11:46AM  
Mar-22-22 04:05PM  
Mar-17-22 03:00PM  
Mar-15-22 09:15AM  
08:59AM  
06:50AM  
Mar-07-22 06:50AM  
Mar-02-22 04:49AM  
Mar-01-22 05:15PM  
Feb-24-22 06:50AM  
Feb-23-22 05:25PM  
Feb-14-22 05:00PM  
Jan-31-22 09:38PM  
Jan-24-22 06:50AM  
Jan-03-22 04:30PM  
Dec-21-21 06:50AM  
Dec-20-21 07:30AM  
Dec-16-21 09:53AM  
Nov-22-21 06:50AM  
06:40AM  
Nov-11-21 06:50AM  
Nov-10-21 04:04PM  
Nov-08-21 04:05PM  
Nov-03-21 10:54PM  
04:03PM  
Nov-02-21 06:55AM  
Nov-01-21 09:00PM  
04:07PM  
02:33PM  
12:36PM  
12:14PM  
12:05PM  
10:35AM  
08:05AM  
06:45AM  
06:30AM  
Oct-29-21 04:30PM  
Oct-28-21 03:05PM  
Oct-01-21 01:10PM  
Sep-20-21 04:30PM  
Sep-17-21 06:50AM  
Sep-03-21 07:12AM  
Aug-31-21 06:50AM  
Aug-06-21 02:31PM  
08:45AM  
07:24AM  
Jul-30-21 03:00PM  
Jul-22-21 04:30PM  
Jul-06-21 06:50AM  
Jul-05-21 01:46AM  
Jun-30-21 09:26AM  
Jun-15-21 04:05PM  
Jun-01-21 04:05PM  
May-27-21 04:30PM  
May-24-21 09:06AM  
May-07-21 11:30AM  
08:05AM  
06:50AM  
06:45AM  
Apr-30-21 03:00PM  
Apr-27-21 01:41PM  
01:24PM  
Apr-26-21 04:30PM  
Apr-06-21 06:50AM  
Mar-22-21 06:27AM  
Mar-09-21 01:00PM  
08:05AM  
06:50AM  
06:45AM  
05:30AM  
Mar-08-21 10:18AM  
Mar-07-21 01:25AM  
Mar-02-21 12:30PM  
Feb-19-21 04:30PM  
Feb-17-21 06:50AM  
Feb-16-21 04:30PM  
Feb-01-21 06:50AM  
Jan-06-21 12:13AM  
Dec-17-20 06:50AM  
Dec-03-20 09:50PM  
Nov-17-20 10:32AM  
Nov-07-20 07:44AM  
Nov-05-20 04:01PM  
06:50AM  
Oct-29-20 06:50AM  
Oct-28-20 12:32PM  
Sep-10-20 07:00PM  
Aug-06-20 08:35AM  
06:50AM  
06:45AM  
Aug-03-20 06:50AM  
Jul-30-20 06:50AM  
Jul-29-20 12:33PM  
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lalwani NikhilPRESIDENT & CEOMar 21Buy27.697,224199,997169,650Mar 23 09:05 PM
Walsh Patrick DDirectorMar 21Buy27.765,000138,79453,388Mar 22 05:39 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYMar 21Buy27.875,000139,342393,226Mar 22 05:37 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYMar 18Buy27.155,000135,744388,226Mar 22 05:37 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSMar 17Buy27.655,000138,2525,000Mar 21 09:58 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSMar 17Buy27.655,000138,25218,460Mar 21 09:58 PM
Thoma JeanneDirectorDec 20Buy46.471,07249,82017,785Dec 22 08:06 PM
Pera Antonio RDirectorDec 07Buy42.263,000126,79419,713Dec 09 04:31 PM
HAUGHEY THOMASDirectorDec 06Buy39.382,50098,45030,202Dec 07 04:17 PM